Although the multistep process of reverse transcription has been well defined, the mechanism of tRNA selection to the primer-binding site (PBS) remains poorly understood. Previous studies have shown that lysyl-tRNA synthetase interacts with Pr55 gag and, in cooperation with Pr160 gag-pol , facilitates the selective incorporation of tRNA 3 Lys into human immunodeficiency virus type 1 (HIV-1) virions (4, 6, 8, 15) . However, packaging of tRNA and the selection of primers to be used in reverse transcription may be separate events, since the tRNA primer enrichment in retroviral virions does not necessarily influence the selection and use of the actual primer used for initiation of reverse transcription (10, 29) . Thus, the selection of the tRNA that is used as the primer might have different constraints than that for the incorporation of the tRNA into virions.
The flexibility of the primer selection process is highlighted by the fact that, in previous studies, we have found that the expression of yeast tRNA Phe in mammalian cells can complement the replication of an HIV-1 provirus in which the PBS was made complementary to the 3Ј-terminal nucleotides of yeast tRNA Phe (10, 11, (25) (26) (27) . In our first series of experiments, we relied on the cotransfection of in vitro-synthesized yeast tRNA
Phe for infectivity (25) (26) (27) . We have used this system to characterize the sequence elements of the tRNA important for selection and use in HIV-1 reverse transcription. Mutations within the T⌿C stem-loop were found to impact on the subsequent infectivity of the virus with a PBS complementary to tRNA Phe (27) . A limitation of this system, though, is that in vitro-transcribed tRNA transfected into the cytoplasm bypasses the normal cellular transport processes for tRNA and, as a result, is not used during protein synthesis. Understanding of the primer selection process should account for the normal intracellular tRNA biogenesis. Following expression and maturation in the nucleus, tRNAs are exported to the cytoplasm by exportin-t (1, 12, 14) . The recognition and subsequent export of tRNAs by exportin-t are based solely on tRNA structural requirements, allowing only mature tRNAs to exit the nucleus (1) . In the cytoplasm, the tRNA is aminoacylated by its cognate aminoacyl-tRNA synthetase. The interaction between the tRNA and the aminoacyl-tRNA synthetase is primarily mediated by tRNA structure; complete association and aminoacylation are facilitated by identity elements present on the tRNA. Following aminoacylation, the charged tRNA is available to the ribosome for amino acid delivery during translation.
In the current study, we have made use of a complementation system in which yeast tRNA Phe is expressed endogenously. Our previous study suggested a coordination between the tRNA primer selection process and tRNA transport to the cytoplasm; tRNAs that are fully functional for use in protein synthesis are also those that are most efficiently selected by HIV-1 for use in reverse transcription (11) . We have further investigated the role of tRNA conformation as it relates to intracellular transport, inclusion in the channeled tRNA cycle during translation as judged by aminoacylation, and primer selection by HIV-1 using yeast tRNA Phe mutants with various degrees of structural disruptions. The results of our studies highlight the relationship between structural integrity of the tRNA and primer selection.
The 293T and HeLa H1 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetal calf serum and 1% antibiotic-antimycotic (Gibco/BRL, Gaithersburg, Maryland).
Yeast tRNA Phe mutant genes were constructed via PCR extension as previously described (11 The procedure used for complementation of the defective HIV provirus psHIV-Phe has been previously described (25) (26) (27) . The Mammalian Transfection kit (Stratagene, San Diego, California) was used for cotransfection of plasmid DNA (psHIV-Phe, pLGRNL, and either pU6
Phe Wt or pU6 Phe 61 or pU6
Phe 6153 or pU6 Phe 56 or pU6 Phe 545556). Virus production was determined by p24 antigen levels, using a commercially available enzyme-linked immunosorbent assay kit (Beckman Coulter, Miami, FL), and serial dilutions of the virus-containing supernatant were used to transduce HeLa H1 cells. At 12 h after infection, the cells were washed with phosphate-buffered saline and placed under selection with DMEM-XM medium (DMEM containing 10% fetal calf serum, 1% antibiotics, 20 mM HEPES [pH 7.5], 250 g/ml xanthine, and 50 g/ml mycophenolic acid) for 10 to 14 days for the formation of drugresistant colonies. Cell colonies were fixed with 5% trichloroacetic acid and stained with 2% Coomassie blue, and the number of drug-resistant colonies was counted.
The Phe probe oligonucleotide (5Ј-TGCGAA TTCTGTGGATCGAACACAGGACCTCCAGATCTTCAG TCTGGCGCTCTCCCAACTGAGCTAAATCC-3Ј), and U6 probe oligonucleotide (5Ј-CGCTTCACGAATTTGCGTGTC ATCCTTGCGCAGGGGCCATGCTAATCTTCTCTGTAT CGT-3Ј). The probes were 5Ј end labeled with [␥-32 P]ATP using Ready-To-Go T4 polynucleotide kinase (Amersham Pharmacia Biotech, Piscataway, New Jersey). Free nucleotides were removed by centrifugation through ProbeQuant G-50 Micro columns (Amersham Biosciences, Piscataway, New Jersey); equal amounts (15 pmol) of probes were used for each blot (10 6 cpm/pmol). The NorthernMax-Gly kit (Ambion, Austin, Texas) was used for Northern blotting, and BrightStar-Plus (Ambion, Austin, Texas) was used as the positively charged nylon membrane. Blots were exposed on a phosphor screen and analyzed with a PhosphorImager. Isolation and blotting of aminoacylated tRNAs collected from HeLa H1 cells 48 h posttransfection with pU6
Phe Wt, pU6 Phe 61, pU6 Phe 6153, pU6
Phe 56, or pU6 Phe 545556 were carried out as previously described (7).
We have previously described a complementation system using a defective HIV-1 proviral genome (psHIV-Phe) in which the PBS has been mutated to be complementary to the 18 3Ј-terminal nucleotides of yeast tRNA Phe and the env gene has been replaced with an expression cassette containing a gene coding for xanthine-guanosine phosphoribosyltransferase (gpt) driven by the simian virus 40 early promoter (10) . The virus is pseudotyped with the vesicular stomatitis virus G protein expressed from the pLGRNL plasmid. Since psHIV-Phe relies fully on the presence of yeast tRNA Phe for infectivity, yet the yeast tRNA Phe is not required by the cell, we have employed this system as a tool for investigating the selection of mutant tRNAs by HIV-1 for use in reverse transcription. The level of infectious virus is determined by the capacity to convert transduced HeLa H1 cells to mycophenolic acid resistance. Infectivity is then calculated by correlating the numbers (27) . The results of these studies established that a single nucleotide change (C61G) significantly compromised the capacity of the tRNA Phe to complement, while a mutation in the loop (U59G) did not substantially affect the capacity for complementation. The mutant tRNA Phe with a single nucleotide substitution (tRNA Phe 61) yields a mismatch of bases adjacent to the T⌿C loop, shortening the tRNA T⌿C stem in the secondary structure ( Fig. 1 ). In the tRNA tertiary structure, the ablated base pairing between nucleotides 61 and 53 is structurally important for the formation of the region at the outer corner of the tRNA L form where the D loop and T⌿C loop interact, known as the D/T region ( Fig. 1) (2, 20, 21) . A second tRNA mutant, Phe 6153, was designed in the current study to compensate for the disruption of the T⌿C stem in the tRNA Phe 61 mutant through a substitution at position 53 (C61G and G53C). Although the second substitution allows for base pairing within the T⌿C stem secondary structure, there is a minor alteration of the tertiary structure due to a disrupted hydrogen bond (2) .
To determine the relationship between the structure and function of endogenously expressed tRNAs with regard to selection by HIV-1, we attempted complementation of psHIVPhe with the yeast tRNA Phe mutants expressed from a U6 polymerase III promoter. The first mutant, tRNA Phe 61, did not have the capacity to be selected by HIV-1 for use in reverse transcription as judged by failure to produce infectious virus ( Fig. 2A) . We did, however, detect levels of infectivity approaching those observed for complementation with wild-type yeast tRNA Phe Phe in the same manner and cell type and attained an equal level of expression (11) . It is probable that the level of transcription from the mutant transgenes is equal to that of wild type, but the tRNAs are not stabilized and maintained in the cell at levels comparable to those for wild-type yeast tRNA
Phe . The mutants were designed with various degrees of structural disruption in the T⌿C stem that might affect binding by exportin-t and subsequent transport to the cytoplasm (1). To determine if any of the mutants were retained in the nucleus, we collected cytoplasmic RNA and performed Northern blot analysis using the probe complementary to yeast tRNA Phe . The mutant tRNA
Phe 61 did not appear in the cytoplasmic pool. The ratios of nuclear to cytoplasmic tRNA for wild type and tRNA Phe 6153 were similar, indicating that tRNA Phe 6153 was transport competent (data not shown). Analysis with an oligonucleotide probe specific for tRNA 3 Lys confirmed that equal amounts of RNA were used for Northern blotting of the three samples, and an oligonucleotide probe complementary to the U6 snRNA was used to ensure that the cytoplasmic fraction did not contain any nuclear RNA (Fig. 2B) (Fig. 2C) . Repeated attempts gave a pattern in which we could not distinguish between aminoacylated and nonaminoacylated tRNA. Most probably, the efficiency of aminoacylation was affected by this mutation; consistent with our previous results, aminoacylation per se is not absolutely required for selection (11) . Collectively, the results from our analysis of these tRNA Phe mutants demonstrate that primer selection was mainly dependent upon nuclear export.
In a previous study, we reported that in vitro-generated tRNA Phe with a complete deletion in the D-loop region complemented the HIV-1 provirus infectivity (11) . However, the expression of a tRNA Phe D-/-minus loop from endogenous promoters did not result in complementation, since the tRNA was sequestered in the nucleus. Thus, we were unable to assess the effect of minor alterations in the tRNA tertiary structure on primer selection. To further address this issue, we designed two yeast tRNA Phe mutants, with various degrees of tertiary structure disruption through ablation of tertiary interactions. The first mutant, tRNA Phe 56, was designed to contain a single nucleotide substitution at position 56 that disrupts the interloop base pairing between nucleotide 56 in the T⌿C loop and nucleotide 19 in the D loop (C56A) (Fig. 1) . A final mutant, tRNA Phe 545556, was constructed that consists of three substitutions at positions 54, 55, and 56 of the tRNA (U54A, U55A, and C56G, respectively). In addition to disruption of the interaction between nucleotides 56 and 19, the tRNA Phe 545556 mutant has a less tertiary structure relative to tRNA Phe 56, due to disrupted interloop base pairing of nucleotides 55 and 18 and because the reverse Hoogsteen base pair, 54-58, is also disrupted. Studies indicate that the reverse Hoogsteen base pair may be more important than interloop base pairs with regard to intracellular tRNA function (28) (Fig. 1) .
We first analyzed the capacity of the tRNAs to complement the defective HIV-1 proviral genome with a PBS complementary to tRNA Phe . Although we did detect complementation with tRNA Phe 56, the levels were less (approximately 75%) than that observed for wild-type tRNA Phe (Fig. 3A) . Further disruption of the tRNA tertiary structure, as found in tRNA Phe 545556, resulted in a tRNA that did not complement infectivity of psHIV-Phe over background.
To determine the nature of the defect of tRNA Phe 545556, we first examined the expression of tRNAs following transfection. Similar to the other mutant tRNA Phe , we found that the expression levels of both tRNA Phe 56 and tRNA Phe 545556 were reduced compared to that of the wild-type tRNA Phe (Fig.  3B) Phe 56 was not efficiently aminoacylated following export to the cytoplasm, suggesting that the conformational requirements for tRNA undergoing transport and efficient aminoacylation are different (Fig. 3C) . The fact that this tRNA was still selected by HIV-1 as a primer for replication demonstrates that aminoacylation, per se, is not an absolute requirement for selection, which is consistent with our previous study in which we found that mutations within the anticodon loop that precluded aminoacylation, due to ablated identity elements, did not eliminate the capacity of this tRNA to be selected by HIV as a primer for replication (11) .
Although the step at which the tRNA primer is selected during the retroviral life cycle remains unresolved, studies from our laboratory and others suggest that the tRNA primer is selected to the PBS prior to encapsidation of the viral genome into progeny virions (9) (10) (11) . In fact, a recent study proposed that the selection of tRNA to the PBS might act as a checkpoint triggering conformational changes in the 5Ј untranslated region and subsequent shift from translation of the viral genome to packaging (3) . Both the tRNA primer selection and the incorporation of primers into virions must be regulated to assure negligible interference with protein synthesis needed for the production of viral proteins. The results of our current study extend our previous report in which we demonstrated that a tRNA Phe D-loop-minus mutant, which had the capacity to complement HIV-1 replication if provided in the cytoplasm, was unable to complement infectivity since it was retained in the nucleus (11) . The tertiary structure of the D-loop-minus mutant is drastically altered as a result of the deletion of approximately one-fourth of the tRNA. The exportin-t/tRNA interaction is needed for the efficient transport of tRNA from the nucleus to the cytoplasm (1). Since exportin-t is known to interact with conformationally intact tRNAs, it is not surprising the D-loop-minus tRNA would not undergo transport. The specificity of the exportin-t/tRNA interaction is highlighted by the fact that two additional mutants, tRNA Phe 61 6153 ). All lanes contain 2 g RNA isolated under acidic conditions; the RNA loaded in lane 2 was adjusted to pH 9.0 and incubated at 37°C for 1 h to serve as the deacylated control. The migration of aminoacylated tRNA and deacylated control tRNA is denoted as AA and DA, respectively. The blots were probed for tRNA 3 Lys or tRNA Phe . The majority of wild-type tRNA Phe and tRNA Lys is present in the aminoacylated form; however, aminoacylated tRNA Phe 6153 was not evident. and tRNA Phe 545556, known to have conformational defects, were not transported and thus did not complement psHIVPhe, establishing a link between nuclear export and selection. One would predict that only those tRNAs that retain sufficient conformation to interact with exportin-t would be targets for capture by HIV-1 as a primer. Why is this important? In the process of biogenesis and transport, the tRNA interacts with a myriad of proteins as it is channeled into translation (1). Thus, HIV-1 is in competition with host cell proteins for the selection of the tRNA primer. Since the nucleus probably contains a large number of aberrant tRNAs, HIV-1 might have evolved to capture these aberrant tRNAs, ostensibly to avoid competition with host cell protein synthesis apparatus as a means to acquire tRNA primers. In fact, analysis of tRNA Phe 61 and tRNA Phe 545556 using in vitro-synthesized tRNA transfected directly into the cytoplasm, which bypasses the need for nuclear transport, revealed that both mutants could complement psHIV-Phe, although the levels were lower than the wild-type tRNA
Phe (approximately 15%) (27). It is possible that the inability of psHIV-Phe to effectively use these mutant tRNAs might be a result of the block in reverse transcription downstream from the selection step; possibly in a later step of reverse transcription, the reverse transcriptase copies the tRNA primer to generate a plus-strand copy of the PBS. The use of aberrant tRNAs could impact negatively on this step, which would result in an overall reduction of successful reverse transcription. Additional experiments will be needed to address this issue. It is now clear, though, that under normal cellular conditions the exportin-t checkpoint for nucleus to cytoplasmic transport, which is dependent upon tRNA conformation, also functions as a checkpoint to ensure selection of tRNAs competent for reverse transcription.
Once the tRNA is transported from the nucleus to the cytoplasm, the tRNA is rapidly incorporated into the translation. At any one time, the tRNA is associated with numerous proteins involved in the channeled tRNA cycle during protein synthesis (22, 24) . For the most part, the tRNA is found in a ternary complex with EF1A-GTP prior to interaction with the ribosome. The tRNA in the complex is aminoacylated with the cognate amino acid. Following participation in protein synthesis, the tRNA is released from the E site of the ribosome and reacquired by either EF1A-GDP or the appropriate synthetase for reaminoacylation (17) . In our system, at any one time, the majority, if not all, of wild-type tRNA Phe was found to be aminoacylated, similar to what was seen for tRNA 3 Lys (11), indicating participation in host cell translation. The results from our current study are consistent with our previous work in which we found that the most efficient complementation occurred with the wild-type yeast tRNA
Phe that was present in a Phe 6153 mutants complemented psHIV-Phe and were not aminoacylated following transport to the cytoplasm. While it is clear that HIV-1 can select primers that do not maintain the capacity to be charged with an amino acid, interaction with the aminoacyl-tRNA synthetase might be important for efficient selection to the PBS, a point that is highlighted upon examination of the structural differences between the tRNA Phe 56 mutant and the tRNA Phe 6153 mutant. Since phenylalanyl-tRNA synthetase displays a higher degree of selectivity at the level of binding than at the level of catalysis and is sensitive to variances in tRNA conformation, the tRNA Phe 56 and tRNA Phe 6153 mutants would be expected to interact with the synthetase with different affinities (18, 23) . Thus, the distinct levels of complementation by tRNA Phe 56 and tRNA Phe 545556 may be a result of their affinities for the synthetase enzyme. It is possible that tRNA Phe 6153 and tRNA Phe 56 might be defective for aminoacylation in vivo due to a lowered capacity to compete with the wild-type (mammalian) tRNA
Phe for interaction with EF1A or the synthetase. The inability to effectively interact with these proteins could result in a loss of intracellular stability, manifested as the lower levels of tRNAs that we detected in our analysis. If one takes into consideration the relative levels of the tRNA Phe 56 and tRNA Phe 6153 mutants compared to wild-type tRNA Phe (mutants expressed at levels approximately 20% of wild type), the amounts of complementation were similar.
We speculate that the tRNA Phe mutants, by virtue of their competency for nucleocytoplasmic transport, are found within the same intracellular pools as the wild-type tRNA Phe . This would be consistent with the concept of a nebula of proteins and substrates (including tRNA) required for protein synthesis that is around polyribosomes during translation (16) . If this is the case, selection of the tRNA might occur from this nebula in conjunction with translation of the viral genome. A relationship between translation and encapsidation of genomic HIV-1 RNA has recently been described (19) . Furthermore, consistent with this proposal, studies have shown that lysl-tRNA synthetase (4) or EF1A (5) is found in HIV-1 virions. Thus, the lines between protein synthesis specific for HIV-1, such as Ϫ1 frameshifting, usage of internal ribosomal entry sites, and even codon preference on selection of primer tRNA by HIV-1, will need to be further explored to resolve the relationships with primer selection. 
